Orchestra BioMed Holdings, Inc. announced an underwritten public offering on August 1, 2025, of approximately 9.4 million shares at $2.75 each, aiming to raise around $40 million for its medical programs and general corporate purposes. The offering closed on August 4, 2025, and included pre-funded warrants to purchase an additional 5.1 million shares.